Twin Tree Management
NVCR icon

Twin Tree Management’s NovoCure NVCR Stock Holding History

Twin Tree Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19
Closed -$1K – 1578
2022
Q2 		$1K Buy
+19
New +$1.43K ﹤0.01% 1441
2020
Q2 		– Sell
-150,592
Closed -$10.1M – 1630
2020
Q1 		$10.1M Buy
+150,592
New +$11.9M 0.05% 324

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Twin Tree Management's NVCR Position: Q3 2022 in Review

Twin Tree Management sold out of NovoCure (NVCR) in Q3 2022, closing a stake of 19 shares — an estimated $1K sold.

Twin Tree Management first reported a position in NVCR in Q1 2020 and held it in 2 quarters. The position peaked at $10.1M in Q1 2020. 303 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

  • Twin Tree Management reported no remaining NovoCure position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 19 NovoCure shares in Q3 2022, an estimated $1K.
  • Twin Tree Management first reported a position in NovoCure in Q1 2020 and held it in 2 quarters.
  • Twin Tree Management's NovoCure position peaked at $10.1M in Q1 2020.
  • 303 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.